EUVIMEDEUVIMED entdecken
Crossref

An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria

Linfu Chen, Zheyu Kang, Jingjing Shen, Rui Zhao, Yu Miao, Lin Zhang, Zixuan Zheng, Zhemin Zhang, Nanhui Liu, Cheng Wang, Huapan Fang, Jun Zhou und 4 weitere

Science Bulletin · 2024-08 · 69 (16) · 2565-2579

DOI: 10.1016/j.scib.2024.06.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Bulletin, 2024-08. Verfasst von Linfu Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, S…. Hauptthemen laut MEDLINE: Fusobacterium nucleatum, Bacterial Vaccines, Colorectal Neoplasms. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fusobacterium nucleatum (F. nucleatum), an oral anaerobe, is prevalent in colorectal cancer and is closely related to increased cancer cell growth, metastasis, and poor treatment outcomes. Bacterial vaccines capable of selectively eliminating bacteria present a promising approach to targeting intratumor F. nucleatum, thereby enhancing cancer treatment. Although adjuvants have been employed to enhance the immune response, the vaccine's effectiveness is constrained by inadequate T-cell activation necessary for eradicating intracellular pathogens. In this study, we developed a minimalistic, biomimetic nanovaccine by integrating highly immunostimulatory adjuvant cholesterol-modified CpG oligonucleotides into the autologously derived F. nucleatum membranes. Compared to the traditional vaccines consisting of inactivated bacteria and Alum adjuvant, the nanovaccine coupled with bacterial membranes and adjuvants could remarkably improve multiple antigens and adjuvant co-delivery to dendritic cells, maximizing their ability to achieve effective antigen presentation and strong downstream immune progress. Notably, the nanovaccine exhibits outstanding selective prophylactic and therapeutic effects, eliminating F. nucleatum without affecting intratumoral and gut microbiota. It significantly enhances chemotherapy efficacy and reduces cancer metastasis in F. nucleatum-infected colorectal cancer. Overall, this work represents the rational application of bacterial nanovaccine and provides a blueprint for future development in enhancing the antitumor effect against bacterial-infected cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fusobacterium nucleatumBacterial VaccinesColorectal NeoplasmsAnimalsHumansMiceOligodeoxyribonucleotidesNanoparticlesGastrointestinal MicrobiomeDendritic CellsCholesterolFemaleCancer VaccinesAdjuvants, VaccineCell Line, TumorAdjuvants, ImmunologicNanovaccines

Stichwörter der Autor:innen

Bacterial vaccineBiomimetic nanomedicineChemotherapyColorectal cancerFusobacterium nucleatum

Substanzen

Bacterial VaccinesOligodeoxyribonucleotidesCPG-oligonucleotideCholesterolCancer VaccinesAdjuvants, VaccineAdjuvants, ImmunologicNanovaccines

Autor:innen und Institutionen

  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou 215123, China.
  • Department of Gynecologic Oncology, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.
  • Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou 215123, China. Electronic address: chenqian@suda.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, L., Kang, Z., Shen, J., Zhao, R., Miao, Y., Zhang, L., Zheng, Z., Zhang, Z., Liu, N., Wang, C., Fang, H., Zhou, J., Wang, Y., Liu, Z., Yang, Y., & Chen, Q. (2024). An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria. Science Bulletin, 69(16), 2565-2579. https://doi.org/10.1016/j.scib.2024.06.016

Vancouver

Chen L, Kang Z, Shen J, Zhao R, Miao Y, Zhang L, et al. An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria. Science Bulletin. 2024;69(16):2565-2579. doi:10.1016/j.scib.2024.06.016

BibTeX
@article{Chen2024,
  author = {Chen, Linfu and Kang, Zheyu and Shen, Jingjing and Zhao, Rui and Miao, Yu and Zhang, Lin and Zheng, Zixuan and Zhang, Zhemin and Liu, Nanhui and Wang, Cheng and Fang, Huapan and Zhou, Jun and Wang, Yudong and Liu, Zhuang and Yang, Yang and Chen, Qian},
  title = {An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria},
  journal = {Science Bulletin},
  year = {2024},
  volume = {69},
  number = {16},
  pages = {2565--2579},
  doi = {10.1016/j.scib.2024.06.016}
}
Kostenlos starten →